Article Information
History
- January 3, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 3, 2022 - 21:18).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brian J. Willett1,#,*,
- Joe Grove1,*,
- Oscar A MacLean1,*,
- Craig Wilkie2,*,
- Nicola Logan1,*,
- Giuditta De Lorenzo1,*,
- Wilhelm Furnon1,*,
- Sam Scott1,*,
- Maria Manali1,*,
- Agnieszka Szemiel1,
- Shirin Ashraf1,
- Elen Vink1,
- William Harvey1,
- Chris Davis1,
- Richard Orton1,
- Joseph Hughes1,
- Poppy Holland3,
- Vanessa Silva3,
- David Pascall4,
- Kathryn Puxty3,
- Ana da Silva Filipe1,
- Gonzalo Yebra5,
- Sharif Shaaban5,
- Matthew T. G. Holden5,6,
- Rute Maria Pinto1,
- Rory Gunson3,
- Kate Templeton7,
- Pablo Murcia1,
- Arvind H. Patel1,
- The COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators,
- The COVID-19 Genomics UK (COG-UK) Consortium***,
- The G2P-UK National Virology Consortium,
- The Evaluation of Variants Affecting Deployed COVID-19 Vaccines (EVADE) investigators,
- John Haughney3,**,
- David L. Robertson1,**,
- Massimo Palmarini1,**,
- Surajit Ray2,** and
- Emma C. Thomson1,3,8,#,**
- 1MRC-University of Glasgow Centre for Virus Research, UK, G61 1QH.
- 2School of Mathematics & Statistics, University of Glasgow, UK
- 3NHS Greater Glasgow & Clyde, Glasgow, UK
- 4MRC Biostatistics Unit, University of Cambridge
- 5Public Health Scotland
- 6School of Medicine, University of St Andrews
- 7NHS Lothian
- 8London School of Hygiene and Tropical Medicine, London, UK
- ↵#Corresponding authors: Professor Emma Thomson and Professor Brian Willett, MRC-University of Glasgow Centre for Virus Research, UK, G61 1QH. emma.thomson{at}glasgow.ac.uk and brian.willett{at}glasgow.ac.uk
Posted January 03, 2022.
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
